MedPath

To Compare Side Effects Of ECT Vs Ketamine

Not Applicable
Conditions
Health Condition 1: F332- Major depressive disorder, recurrent severe without psychotic features
Registration Number
CTRI/2024/01/061652
Lead Sponsor
Department of Psychiatry Sion hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients above 18 years of age.

Patients diagnosed with MDD and not better with medications.

Patients requiring ECT.

Exclusion Criteria

Patient not willing to give consent.

Pregnant and Lactating woman.

Patients having contraindications for ECT and Ketamine.

Patients with comorbid substance use except Nicotine.

Patients who have received either ECT or ketamine during the past 6 months.

Patients with a history of non-responsiveness to ECT or ketamine.

Patients with any condition that is known to be associated with cognitive

impairment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ECT Has More Neurocognitive Side Effects Than KetamineTimepoint: Baseline, 1 Week Post Treatment Endpoint, 1 Month Post Treatment Endpoint
Secondary Outcome Measures
NameTimeMethod
To Check How Much Less Neurocognitive Side Effects Does Ketamine Have As Compared To ECTTimepoint: Baseline, 1 Week Post Treatment Endpoint, 1 Month Post Treatment Endpoint
© Copyright 2025. All Rights Reserved by MedPath